Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.

MLA

Burade, Vinod, et al. “Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.” Clinical Ophthalmology (Auckland, N.Z.), vol. 14, Sept. 2020, pp. 2747–55. EBSCOhost, https://doi.org/10.2147/OPTH.S259331.

APA

Burade, V., Zalawadia, R., Patel, A., & Ogundele, A. (2020). Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease. Clinical Ophthalmology (Auckland, N.Z.), 14, 2747–2755. https://doi.org/10.2147/OPTH.S259331

Chicago

Burade, Vinod, Rishit Zalawadia, Alpesh Patel, and Abayomi Ogundele. 2020. “Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.” Clinical Ophthalmology (Auckland, N.Z.) 14 (September): 2747–55. doi:10.2147/OPTH.S259331.